Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells

Fig. 3

BCL9-siRNA effectively interfered with the expression of BCL9 in CaoV3 and ES-2 ovarian cancer cell lines. a Western blot showed that BCL9 expression was relatively high in CaoV3 and ES-2 ovarian cancer cell lines. b The results of the immunocytofluorescence test suggested that BCL9 was located in the nucleus and cytoplasm of CaoV3 and ES-2 cells, but mainly in the nucleus. c, d Western blot showed that BCL9 protein expression levels significantly decreased in BCL9-siRNA-transfected CaoV3 and ES-2 ovarian cancer cell lines (*P < 0.05, **P < 0.01)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us